Search Medical Condition
Please enter condition
Please choose location from dropdown

Darien, Connecticut Clinical Trials

A listing of Darien, Connecticut clinical trials actively recruiting patient volunteers.

RESULTS

Found (108) clinical trials

A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease

This study will evaluate Advanced Laboratory Services Borrelia diagnostic test by culturing Borrelia spirochetes from human serum in subjects with early or late Lyme disease. This is an 8 month study. Subjects entering the study will have two blood samples collected one month apart if they have early Lyme disease ...

Phase N/A

0.75 miles

Learn More »

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic Endovascular System

The study is designed to evaluate the safety and efficacy of ultrasound accelerated thrombolysis using the EkoSonic® Endovascular System with standard infusion of a thrombolytic drug for PTS and chronic DVT. Clinical effectiveness will be evaluated using a standard measure of severity of post-thrombotic syndrome over a year.

Phase N/A

0.75 miles

Learn More »

Revolution Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

This study intends to enroll up to 121 subjects at up to 12 investigational sites in the United States. This is a single-arm study of the Revolution Peripheral Atherectomy System in subjects with peripheral arterial disease (PAD). The primary safety endpoint is freedom from 30-day Major Adverse Events (MAE), defined ...

Phase N/A

0.75 miles

Learn More »

Effect of VarIthena on Wound Healing in VLU

This 12 month, multicenter, open-label registry is designed to collect treatment and outcome data related to subjects treated with Varithena for GSV system and/or AASV incompetence resulting in VLU. Subjects are treated per Investigator's SoC and in accordance with the FPI and IFU. For subjects with healed ulcers during the ...

Phase N/A

0.75 miles

Learn More »

Cook Enforcer Post-Market Study

The purpose of this study is to evaluate the performance of the Cook Advance Enforcer 35 Focal-Force PTA Balloon Catheter (or Enforcer balloon) in treating narrowed blood vessels compared to treatment with a conventional angioplasty balloon.

Phase N/A

0.75 miles

Learn More »

A Study of LY3002813 and LY3202626 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)

The purpose of this study is to evaluate the safety, tolerability and efficacy of LY3002813 alone and in combination with LY3202626 in early symptomatic Alzheimer's disease.

Phase

3.08 miles

Learn More »

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

The purpose of this study is to evaluate the efficacy of pimavanserin by comparing pimavanserin with placebo in preventing a relapse of psychotic symptoms in subjects with dementia-related psychosis and who were stabilized after 12 weeks of open label pimavanserin treatment.

Phase

3.08 miles

Learn More »

A Study of LY3154207 in Participants With Parkinson's Disease Dementia

A randomized placebo-controlled trial in individuals with Parkinson's disease dementia to evaluate the safety and efficacy of three doses of study drug LY3154207 in participants with mild-to-moderate Parkinson's disease dementia treated for 12 weeks.

Phase

3.08 miles

Learn More »

Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years With OLE

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Part 1: Approximately 20 weeks (includes screening and double-blind treatment). Screening will be performed based on the inclusion exclusion criteria specified in the study protocol. ...

Phase

3.08 miles

Learn More »

You may be eligible to participate in a clinical research study of an investigational medication to lower your risk of heart attack or stroke. Qualifications for this investigational drug study include: A simple blood test called c-reactive protein may predict the future risk or heart attack and or stroke. Men ...

Phase N/A

3.08 miles

Learn More »